Search
Search Results
##search.searchResults.foundPlural##
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4679PDF: 1820HTML: 1339 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
2003PDF: 1065HTML: 400 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7184PDF: 3814HTML: 848 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3226PDF: 1086HTML: 3241 -
DECREASED CD10 EXPRESSION IN THE BONE MARROW NEUTROPHILS OF HIV POSITIVE PATIENTS
1412PDF: 951HTML: 1206Coverletter: 295 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2378PDF: 791HTML: 373 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
4001PDF: 981HTML: 480Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 254 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3548PDF: 632HTML: 733 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1417PDF: 549HTML: 447 -
-
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1924PDF: 975HTML: 1029Referring article: 802 -
IMMUNOLOGY OF TUBERCULOSIS
5920PDF: 2349HTML: 7374Untitled: 251 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3871PDF: 1348HTML: 3957Untitled: 288Untitled: 319 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1448PDF: 1227HTML: 169 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3566PDF: 1340HTML: 8419 -
-
CIRCUMCISION IN MALES WITH BLEEDING DISORDERS
2070PDF: 989HTML: 6837Cover letter: 213 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3033PDF: 1048HTML: 7520 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10719PDF: 3377HTML: 1654 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3300PDF: 1698HTML: 403 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
785PDF: 505HTML: 6291 -
THE HEMATOLOGICAL PARAMETERS AND BIOCHEMICAL MARKERS OF IRON STATUS IN ALFA-THALASSEMIA 3.7KB DELETION FROM METROPOLITAN REGION OF MANAUS, AMAZONAS, BRAZIL. alfa-Thalassemia 3.7 deletion From Amazonas, Brazil.
4336PDF: 722HTML: 505 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1648PDF: 1340HTML: 559 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
2150PDF: 1373HTML: 11590Figure1: 212Figure 2: 231 -
-
Sickle cell disease and Bartonella spp. infection
1419PDF: 1455HTML: 514







